TP53 and central nervous system cancer: A subsequent study demonstrated that at least some of these effects are mediated by direct or indirect transcription factor-like activity of the sGC β1 protein, targeting the promotor of the TP53 gene to influence the levels of p53 tumor suppressor and thus regulate the cell cycle progression in glioma [160].